Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
California was already contending with a home insurance crisis due to unpredictable weather events. Then came this week’s fires.
England had a rude awakening this week, as the United Kingdom was transported back in time to one of the most tumultuous years in its history.
Defined outcome ETFs have long promised virtually risk-free investing, but also place significant caps on potential gains.